Detailed price information for Medicenna Therapeutics Corp (MDNA-T) from The Globe and Mail including charting and trades.

ABSTRACT: Introduction: Interstitial lung disease (ILD) is a progressive pulmonary disease, and many patients with ILD eventually require long-term oxygen therapy (LTOT) despite intensive treatment.

If every user like you gave just $1 a year, we could sustain our mission of transparency forever.